PR Newswire Cellenkos Announces FDA Clearance of Investigational New Drug (IND) Application for Phase 1b/ 2a Trial of CK0802 in Steroid-Refractory Graft-versus-Host Disease (GVHD) by Money Compass May 4, 2026
PR Newswire CaoCao Inc. Unlocks Cross-Border Ride-Hailing Service: One App, Six Countries, Ten Cities, Zero Hassle by Money Compass October 23, 2025
PR Newswire Medison Strengthens its Global Commercialization Platform, Appoints Francis Wan as VP, GM Asia Pacific by Money Compass October 23, 2025
PR Newswire Medison Strengthens its Global Commercialization Platform, Appoints Francis Wan as VP, GM Asia Pacific by Money Compass October 23, 2025
PR Newswire HanchorBio’s Novel CD47-SIRPα Therapeutic HCB101 Accepted for Publication in Prestigious Journal of Hematology & Oncology by Money Compass October 23, 2025
PR Newswire JCET Posts Record Q3 Revenue, Profit Before Tax Up 29.3% Year-on-Year by Money Compass October 23, 2025
PR Newswire JCET Posts Record Q3 Revenue, Profit Before Tax Up 29.3% Year-on-Year by Money Compass October 23, 2025
PR Newswire JCET Posts Record Q3 Revenue, Profit Before Tax Up 29.3% Year-on-Year by Money Compass October 23, 2025
PR Newswire Enclustra Launches Regional HQ in Singapore, Swiss Firm Eyes Talent Growth in High-Tech Manufacturing, R&D by Money Compass October 23, 2025
PR Newswire Enclustra Launches Regional HQ in Singapore, Swiss Firm Eyes Talent Growth in High-Tech Manufacturing, R&D by Money Compass October 23, 2025
PR Newswire KuPool Debuts Under KuCoin Ecosystem, Redefining Secure and Transparent Crypto Mining by Money Compass October 23, 2025
